|
SRRT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.397200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.810200E-01 |
| Normal-vs-Stage2 |
7.771000E-01 |
| Normal-vs-Stage3 |
5.843000E-01 |
| Normal-vs-Stage4 |
1.946800E-01 |
| Stage1-vs-Stage2 |
7.062600E-01 |
| Stage1-vs-Stage3 |
6.689000E-01 |
| Stage1-vs-Stage4 |
3.269800E-01 |
| Stage2-vs-Stage3 |
6.017400E-01 |
| Stage2-vs-Stage4 |
3.702000E-01 |
| Stage3-vs-Stage4 |
5.528800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.386200E-01 |
| Normal-vs-AfricanAmerican |
9.612600E-01 |
| Normal-vs-Asian |
7.929600E-01 |
| Caucasian-vs-AfricanAmerican |
9.083000E-01 |
| Caucasian-vs-Asian |
8.582000E-01 |
| AfricanAmerican-vs-Asian |
8.705600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.718200E-01 |
| Normal-vs-Female |
8.920400E-01 |
| Male-vs-Female |
8.955400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.696000E-01 |
| Normal-vs-Extreme_Weight |
9.716600E-01 |
| Normal-vs-Obese |
7.631000E-01 |
| Normal-vs-Extreme_Obese |
4.140200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.882600E-01 |
| Normal_Weight-vs-Obese |
4.943200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.901800E-01 |
| Extreme_Weight-vs-Obese |
7.332600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.673600E-01 |
| Obese-vs-Extreme_Obese |
5.091400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.558600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.162000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.598600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.836600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.241000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.561600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.602600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.380800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.478000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.160800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.955700E-02 |
| Normal-VS-Type2 PRCC |
1.156780E-04 |
| Normal-VS-KIRP CIMP |
9.692300E-02 |
| Normal-VS-Unclassified PRCC |
3.032600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.09119396746382E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.715440E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.363300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.252000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.121100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.875800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.982600E-01 |
| Normal-vs-N1 |
6.452200E-01 |
| Normal-vs-N2 |
4.262200E-02 |
| N0-vs-N1 |
6.125000E-01 |
| N0-vs-N2 |
2.544000E-01 |
| N1-vs-N2 |
1.053820E-01 |
|
|
